Publications

Research papers

Zhou Q, Godwin DW, O’Malley DM and Adams PR. Visualization of calcium influx through channels that shape the burst and tonic modes of thalamic relay cells.  J.  Neurophysiol. 77: 2816-2825, 1997.

Cox CL, Zhou Q and Sherman SM. Glutamate locally activates dendritic outputs of thalamic interneurons. Nature 394: 478-482, 1998.

Zhou Q, Xiao MY and Nicoll RA. Contribution of cytoskeleton to the internalization of AMPA receptors. Proc. Natl. Acad. USA. 98: 1261-1266, 2001.

Zhou Q, Tao HW and Poo M-m. Reversal and stabilization of synaptic modifications in a developing visual system.  Science 300, 1953-1957, 2003.

Zhou Q, Homma, K and Poo, M-m. Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 44:749-757, 2004.

Wang X, Yang Y and Zhou Q. Independent expression of synaptic and morphological plasticity associated with long-term depression. J. Neurosci. 27:12419-29, 2007.

Yang Y, Wang X, Frerking M and Zhou Q. Delivery of AMPA receptors to perisynaptic sites precedes the full expression of long-term potentiation. Proc. Natl. Acad. USA. 105: 11388-11393, 2008.

Yang Y, Wang XB, Zhou Q. Perisynaptic GluR2-lacking AMPA receptors control the reversibility of synaptic and spines modifications. Proc. Natl. Acad. USA. 107: 11999-2004, 2010.

Hanson J, Weber M, Meilandt W, Wu T, Luu T, Deng L, Shamloo M, Sheng M, Scearce-Levie K and Qiang Zhou.  GluN2B antagonism affects interneurons and leads to immediate and persistent changes in synaptic plasticity, oscillations, and behavior. Neuropsychopharmacology. 38(7):1221-33, 2013.

Hanson J, Deng L, Hackos D, Lo JS, Lauffer B, Steiner P and Zhou Q.  HDAC2 cell-autonomously suppresses excitatory and enhances inhibitory synaptic functions in hippocampal neurons. J. Neurosci. 33:5924-9, 2013.

Hanson J, Meilandt W, Gogineni A, Reynen P, Herrington J, Weimer R, Scearce-Levie K and Zhou Q. Chronic GluN2B Antagonism Disrupts Behavior in Wild-Type Mice Without Protecting Against Synapse Loss or Memory Impairment in Alzheimer's Disease Mouse Models. J. Neurosci. 34(24):8277-88, 2014.

Yan R and Zhou Q. Coding of "Home Cage" by PFC Neurons. Neuroscience. 393:33-41, 2018.

Yao L, Grand T, Hanson J, Paoletti P and Zhou Q. Higher ambient synaptic glutamate at inhibitory versus excitatory neurons differentially impacts NMDA receptor activity. Nat Commun. 9(1):4000, 2018.

Yan R, Wang T and Zhou Q. Elevated dopamine signaling from ventral tegmental area to prefrontal cortical parvalbumin neurons drives conditioned inhibition. Pro. Natl. Acad. USA. 116(26): 13077-13086, 2019.

Yan R, Wang T, Ma X, Zhang X, Zheng R and Zhou Q. Prefrontal inhibition drives formation and dynamic expression of probabilistic Pavlovian fear conditioning. Cell Rep. 36(6):109503, 2021.

Yao L, Rong Y, Ma X, Li H, Deng D, Chen Y, Yang S, Peng T, Ye T, Liang F, Xu N and Zhou Q. Extrasynaptic NMDA Receptors Bidirectionally Modulate Intrinsic Excitability of Inhibitory Neurons. J. Neurosci. 42(15):3066-3079, 2022.

Wang T, Yan R, Zhang X, Wang Z, Duan H, Wang Z and Zhou Q. Paraventricular Thalamus Dynamically Modulates Aversive Memory via Tuning Prefrontal Inhibitory Circuitry. J. Neurosci. 42(20):3630-3646, 2023.

Chen Y, Yan P, Wei S, Zhu Y, Lai J and Zhou Q. Ketamine metabolite alleviates morphine withdrawal-induced anxiety via modulating nucleus accumbens parvalbumin neurons in male mice. Neurobiol. Dis. 1:186:106279, 2023.

Wang Z, Wang Z and Zhou Q. Modulation of learning safety signals by acute stress: periventricular thalamus and prefrontal inhibition. Neuropsychopharmacology. 49(6):961-973, 2024.

Review articles

Zhou Q and Poo M-m. Reversal and consolidation of activity-induced synaptic modifications. Trends. Neurosci. 27:378-83, 2004.

Yang Y and Zhou Q. Spine modifications associated with long-term potentiation. Neuroscientist 15: 464-76, 2009.

Paoletti P, Bellone C and Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and diseases.  Nat. Rev. Neuroscience. 14(6):383-400, 2013.

Zhou Q and Sheng M. NMDA receptors in nervous system diseases. Neuropharmacology 74:69-75, 2013.